GHRP-2 vs GHRP-6 China Wholesale Buyer Guide

Define GHRP-2 and GHRP-6 independently

Use full controlled names and molecular identity references for each peptide. Record form, target purity, requested strength, vial count and research-use status on separate order lines. Do not let the shared GHRP prefix imply interchangeability. Ask the supplier to map internal product codes to the buyer specification and preserve that mapping in the COA and packing list.

Compare overlapping and unique strengths

Both products have 5mg and 10mg pages, while GHRP-2 also has 15mg. Build a matrix showing strength, vials, total material, fill tolerance, lot and price basis. Confirm whether mixed-product or mixed-strength MOQs are permitted. Each configuration still needs its own labels and traceability even when commercial tiers combine quantities.

Require molecule-specific analytical reports

Review HPLC purity and MS identity for the exact GHRP-2 or GHRP-6 lot. The similarity of product names makes sample identifiers especially important. Check chromatograms, expected molecular information, dates and authorizations. A report for GHRP-6 cannot qualify GHRP-2, and a generic catalog COA cannot qualify either offered batch.

Audit content and finished-lot genealogy

Require evidence supporting each 5mg, 10mg or 15mg statement separately from purity. If one parent lot is filled into several strengths, ask for reconciliation and finished-lot links. If different parent lots are used, keep their COAs and inventory separated. Confirm whether price comparisons use nominal content, net peptide or another basis.

Prevent warehouse and receiving swaps

Specify distinct labels, lot numbers and secondary packaging. Ask how warehouse picking, line clearance and final reconciliation distinguish GHRP-2 from GHRP-6. Mixed cartons need a clear packing list organized by product, strength and lot. Receiving staff should inspect representative vials and quarantine any unit whose label, lot or strength conflicts with approved records.

Map the supplier and batch ownership chain

Document the legal seller, manufacturing site, analytical laboratory, filling or packaging site, inventory owner and dispatch entity for the exact SKU. A supplier can coordinate qualified partners, but the arrangement and responsibilities should be transparent. Ask who releases the batch, who investigates deviations and who retains original production and test records. Require notification before a critical party changes. This supply-chain map helps buyers distinguish technical control from a generic factory claim and clarifies which company is accountable when labels, documents or received quantities do not match the approved order.

Build one comparable wholesale quotation matrix

Send every supplier the same fields: exact identity, strength, vial count, total material, target purity, identity method, quantitative-content basis, offered lot, testing status, packaging, documents, lead time and shipping term. Mark missing answers as exceptions rather than filling gaps with assumptions. Separate one-time testing or setup costs from recurring unit costs. This creates one auditable decision record for scientific, purchasing and quality reviewers and prevents the lowest-looking offer from winning simply because it describes less work.

Apply a batch-focused quality-control review

Define methods and acceptance criteria before purchase. HPLC commonly supports chromatographic purity and mass spectrometry can support identity, but neither should imply untested attributes. Check sample identifiers, dates, report numbers, units and lot relationships. Use the quality-control framework to connect each claim to evidence. Preserve original reports, record revisions and investigate contradictions before accepting the lot.

Create a documentation gate before dispatch

List the required COA, analytical attachments, SDS, specification, supported storage statement, label proof, invoice and packing list in the RFQ. Reconcile product, strength, lot, quantity and revision across documents using the documentation guide. The importer remains responsible for current destination rules. Research-use wording supports clarity but neither guarantees customs entry nor replaces destination-specific due diligence.

Qualify logistics and receiving controls

Confirm dispatch location, carrier, shipping term, packaging configuration and realistic production, release and transit windows. Reject promises of guaranteed clearance or misleading declarations. On receipt, record package condition, seals, product, strength, lot and quantity, then link internal inventory to the supplier batch. Quarantine unexplained discrepancies until a documented quality decision is completed.

Use actual performance for repeat-order approval

A controlled evaluation order should use the same specification planned for wholesale scale. Assess document accuracy, package condition, delivery time, communication and corrective response, and consider buyer-arranged testing appropriate to risk with documented sample custody. For every new lot, repeat the batch review. Require notification before changes to manufacturing, testing, filling, material specification, labels or packaging.

Related products and same-category guides

• GHRP-2 5mg
• GHRP-2 10mg
• GHRP-2 15mg
• GHRP-6 5mg
• GHRP-6 10mg
• Sermorelin China Wholesale Guide
• CJC-1295 + Ipamorelin Guide

Frequently asked questions